Clinical trials
Adenocarcinoma of Lung trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 3 |
| Novartis Pharmaceuticals | 3 |
| Radiation Therapy Oncology Group | 3 |
| NCIC Clinical Trials Group | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Morphotek | 1 |
| NRG Oncology | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 21 |
| Carcinoma, Non-Small-Cell Lung | 18 |
| Lung Neoplasms | 15 |
| Adenocarcinoma, Bronchiolo-Alveolar | 4 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Ductal | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.